Prevention of radiocontrast-induced nephropathy with N-acetylcysteine after cardiac angiography in diabetic patients with renal dysfunction

Mid-Taiwan Journal of Medicine

Volumn 12, Issue 4, 2007, Pages 173-183

  Hsu, Chung Ho ^b   Lee, Jeng Di ^a   Lo, Ping Han ^b   Lin, Jen Jyh ^b   Chang, Hui Wen ^b   Chou, Hsiang Tai ^b  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Cardiac angiography; N acetylcysteine; Radiocontrast induced nephropathy

Indexed keywords

ACETYLCYSTEINE; ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; IOHEXOL; METFORMIN; ORAL ANTIDIABETIC AGENT; PLACEBO;

ABSENCE OF SIDE EFFECTS; ADULT; AGE; AGED; ANGIOGRAPHY; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIAC ANGIOGRAPHY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; DIABETIC PATIENT; DRUG CONTRAINDICATION; FEMALE; HIGH RISK POPULATION; HOSPITALIZATION; HUMAN; INCIDENCE; KIDNEY DISEASE; LENGTH OF STAY; MALE; RADIOCONTRAST INDUCED NEPHROPATHY; RANDOMIZED CONTROLLED TRIAL; RENAL PROTECTION; RISK ASSESSMENT; RISK FACTOR; SEX; SINGLE BLIND PROCEDURE;

EID: 38149026132     PISSN: 10293507     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Pendergrass EP, Cliamberlin GW, Godfrey EW, et al. A survey of deaths and unfavorable sequelae following the administration of contrast media. Am J Radiol 1942;48:741-62.
2. Hou SH, Bushinsky DA, Wish JB, et al. Hospital-acquired renal insufficiency: a prospective study. Am J Med 1983;74:243-8.
3. Levy EM, Viscoli CM, Horwitz RI. The effect of acute renal failure on mortality. A cohort analysis. JAMA 1996;275:1489-94.
4. Solomon R, Weiner C, Mann D, et al. Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents. N Engl J Med 1994;331:1416-20.
5. Cronin RE. Renal failure following radiologic procedures. Am J Med Sci 1989;298:342-56
6. Porter GA. Contrast-associated nephropathy. [Review] Am J Cardiol 1989;64:22E-26E.
7. Porter GA. Experimental contrast-associated nephropathy and its clinical implications. [Review] Am J Cardiol 1990;66:18F-22F.
8. Parfrey PS, Griffiths SM, Barrett BJ, et al. Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study. N Engl J Med 1989;320:143-9.
9. Taliercio CP, Vlietstra RE, Fisher LU, et al. Risks for renal dysfunction with cardiac angiography. Ann Intern Med 1986;104:501-4.
10. Rich MW, Crecelius CA. Incidence, risk factors and clinical course of acute renal insufficiency after cardiac catheterization in patients 70 years of age or older. A prospective study. Arch Intern Med 1990; 150:1237-42.
11. Berns AS. Nephrotoxicity of contrast media. [Review] Kidney Int 1989;36:730-40.
12. Manske CL, Sprafka JM, Strony JT, et al. Contrast nephropathy in azotemic diabetic patients undergoing coronary angiography. Am J Med 1990;89:615-20.
13. Mueller C, Buerkle G, Buettner HJ, et al. Prevention of contrast-media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty. Arch Intern Med 2002;162:329-30.
14. Rudnick MR, Goldfarb S, Wexler L, et al. Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: a randomized trial. The Iohexol Cooperative Study. Kidney Int 1995;47:254-61.
15. Khoury Z, Schlicht JR, Como J, et al. The effect of prophylactic nifedipine on renal function in patients administered contrast media. Pharmacotherapy 1995; 15:59-65.
16. McCullough PA, Wolyn R, Rocher LL, et al. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 1997;103:368-75.
17. Neumayer HH, Junge W, Kufner A, et al. Prevention of radiocontrast-media-induced nephrotoxicity by the calcium channel blocker nitrendipine: a prospective randomized clinical trial. Nephrol Dial Transplant 1989;4:1030-6.
18. Abizaid AS, Clark CE, Mintz GS, et al. Effects of dopamine and aminophylhine on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency. Am J Cardiol 1999;83:260-3.
19. Gare M, Haviv YS, Ben-Yehuda A, et al. The renal effect of low-dose dopamine in high-risk patients undergoing coronary angiography. J Am Coll Cardiol 1999;34:1682-8.
20. Kurnik BR, Allgren RL, Genter FC, et al. Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy. Am J Kidney Dis 1998;31:674-80.
21. Tepel M, van der Giet M, Schwarzfeld C, et al. Prevention of radiographic contrast-agent-induced reductions in renal function by acetylcysteine. N Engl J Med 2000;343:180-4.
22. Briguori C, Manganelli F, Scarpato P, et al. Acetylcysteine and contrast-agent-associated nephrotoxicity. J Am Coll Cardiol 2002;40:298-303.
23. Kay J, Chow WH, Chan TM, et al. Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial. JAMA 2003;289:553-8.
24. Boccalandro F, Amhad M, Smalling RW, et al. Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast. Catheter Cardiovasc Interv 2003;58:336-41.
25. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31-41.
26. Conover WJ. 1980. Practical Nonparametric Statistics. New York: John Wiley & Sons, 1980:89-90.
27. Chalmers N, Jackson RW. Comparison of iodixanol and iohexol in renal impairment. Br J Radiol 1999;72: 701-3.
28. Chertow GM, Christiansen CL, Cleary PD, et al. Prognostic stratification in critically ill patients with acute renal failure requiring dialysis. Arch Intern Med 1995;155:1505-11.
29. Gruberg L, Mehran R, Dangas G, et al. Acute renal failure requiring dialysis after percutaneous coronary interventions. Catheter Cardiovasc Interv 2001;52: 409-16.
30. Zagler A, Azadpour M, Mercado C, et al. N-acetylcysteine and contrast-induced nephropathy: a meta-analysis of 13 randomized trials. Am Heart J 2006;151:140-5.
31. Diaz-Sandoval LJ, Kosowsky BD, Losordo DW. Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial). Am J Cardiol 2002; 89:356-8.
32. Jones AL, Haynes W, MacGilchrist AJ, et al. N-acetylcysteine (NAC) is a potent peripheral vasodilator. Gut 1994;35:(Suppl 5):S10.
33. Weisberg LS, Kurnik PB, Kurnik BR. Radiocontrast-induced nephropathy in humans: role of renal vasoconstriction. Kidney Int 1992; 41:1408-15.
34. Drager LF, Andrade L, Barros de Toledo JF, et al. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury. Nephrol Dial Transplant. 2004;19:1803-7.
35. Handelman GJ, Walter MF, Adhikarla R, et al. Elevated plasma F2-isoprostanes in patients on long-term hemodialysis. Kidney Int 2001;59:1960-6.
36. Morgan LR, Holdiness MR, Gillen LE. N-acetylcysteine: its bioavailability and interaction with ifosfamide metabolites. Semin Oncol 1983;10(1 Suppl 1):S56-61.
37. Birck R, Krzossok S, Markowetz F, et al. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 2003;362:598-603.
38. Kshirsagar AV, Poole C, Mottl A, et al. N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials. [Review] J Am Soc Nephrol 2004; 15:761-9.
39. Toprak O, Cirit M, Bayata S, et al. The effect of pre-procedural captopril on contrast-induced nephropathy in patients who underwent coronary angiography. Anadolu Kardiyol Derg 2003;3:98-103. (In Turkish; English abstract).
40. Gupta RK, Kapoor A, Tewari S, et al. Captopril for prevention of contrast-induced nephropathy in diabetic patients: a randomized study. Indian Heart J 1999;51: 521-6.
41. Caldicott WJ, Hollenberg NK, Abrams HL. Characteristics of response of renal vascular bed to contrast media. Evidence for vasoconstriction induced by rennin-angiotensin system. Invest Radiol 1970;5: 539-47.
42. Louis BM, Hoch BS, Hernandez C, et al. Protection from the nephrotoxicity of contrast dye. Ren Fail 1996;18:639-46.
43. Brewster UC, Perazella MA. The rennin-angiotensin-aldosterone system and the kidney: effects on kidney disease. [Review] Am J Med 2004; 116:263-72.